Your browser doesn't support javascript.
loading
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale.
Aoyama, Yosuke; Hoshino, Eri; Shimomura, Akihiko; Shimizu, Chikako; Taniyama, Tomoko; Tada, Manami; Yoshida, Nao; Sato, Hitomi; Nonogaki, Kiyomi; Yamamoto, Kazumasa; Yamanaka, Taro; Kizawa, Rika; Yamaguchi, Takeshi; Tanaka, Kiyo; Kobayashi, Yoko; Tamura, Nobuko; Tanabe, Yuko; Miura, Yuji; Kikawa, Yuichiro; Cho, Juhee; Kawabata, Hidetaka.
Afiliación
  • Aoyama Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan. yosuke.aoyama10@gmail.com.
  • Hoshino E; Division of Policy Evaluation, Department of Health Policy, Research Institute, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
  • Shimomura A; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-Ku, Tokyo, Japan.
  • Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-Ku, Tokyo, Japan.
  • Taniyama T; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-Ku, Tokyo, Japan.
  • Tada M; Department of Breast Surgery, Kansai Medical University Hospital, 2-3-1 Shinmachi, Hirakata-Shi, Osaka, Japan.
  • Yoshida N; Department of Breast Surgery, Kansai Medical University Hospital, 2-3-1 Shinmachi, Hirakata-Shi, Osaka, Japan.
  • Sato H; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Nonogaki K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Yamamoto K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Yamanaka T; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Kizawa R; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Yamaguchi T; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Tanaka K; Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Kobayashi Y; Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Tamura N; Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Tanabe Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Miura Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
  • Kikawa Y; Department of Breast Surgery, Kansai Medical University Hospital, 2-3-1 Shinmachi, Hirakata-Shi, Osaka, Japan.
  • Cho J; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Samsung Medical Center, 115 Irwon-Ro, Gangnam-Gu, Seoul, Republic of South Korea.
  • Kawabata H; Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, Japan.
Breast Cancer ; 31(2): 234-242, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38079066
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Límite: Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Límite: Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón